Literature DB >> 35241516

Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model.

Dasa Seveljevic-Jaran1,2, Otto Kalliokoski2, Klas S P Abelson2, Jann Hau2.   

Abstract

BACKGROUND/AIM: This study aimed to investigate the analgesic effects of fluoxetine on Lewis rats of both sexes in the adjuvant-induced arthritis (AIA) rat model. In humans, chronic pain syndromes typical of rheumatoid arthritis (RA) co-exist with depression which is often treated with fluoxetine antidepressant known to have antinociceptive effects.
MATERIALS AND METHODS: The experiment was terminated on day 26, after seven days of oral treatment (days 19-25) with fluoxetine and indomethacin. The effects of treatments were assessed on the final day of the study through measuring body weight, serum concentrations of a1-acid glycoprotein, visual arthritis assessment and post mortem histopathology assessment.
RESULTS: Statistically significant difference was determined in the body weight of male subjects, with indomethacin-treated animals putting on significantly more weight than the vehicle and fluoxetine-treated counterparts. No differences were found between the different treatment groups in other study assessments.
CONCLUSION: The present study did not provide support for analgesic effects of fluoxetine aimed at reducing the severity of the AIA model.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Rheumatoid arthritis; analgesia; fluoxetine; rat model

Mesh:

Substances:

Year:  2022        PMID: 35241516      PMCID: PMC8931903          DOI: 10.21873/invivo.12747

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  43 in total

1.  Validation of a rat behavioral avoidance model from a drug delivery perspective.

Authors:  Meenakshi G Bhat; Raymond M Jordt; M Amin Khan; Christine E Foley; Timothy A Gilbertson
Journal:  Int J Pharm       Date:  2005-10-13       Impact factor: 5.875

2.  Laboratory environmental factors and pain behavior: the relevance of unknown unknowns to reproducibility and translation.

Authors:  Jeffrey S Mogil
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

Review 3.  Evidence-based data on pain relief with antidepressants.

Authors:  D Fishbain
Journal:  Ann Med       Date:  2000-07       Impact factor: 4.709

Review 4.  Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies.

Authors:  S Perrot; R-M Javier; M Marty; C Le Jeunne; F Laroche
Journal:  Rheumatology (Oxford)       Date:  2008-04-29       Impact factor: 7.580

Review 5.  Depression and pain comorbidity: a literature review.

Authors:  Matthew J Bair; Rebecca L Robinson; Wayne Katon; Kurt Kroenke
Journal:  Arch Intern Med       Date:  2003-11-10

6.  The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.

Authors:  Marina Stolina; Brad Bolon; Scot Middleton; Denise Dwyer; Heather Brown; Diane Duryea; Li Zhu; Alison Rohner; James Pretorius; Paul Kostenuik; Ulrich Feige; Debra Zack
Journal:  J Clin Immunol       Date:  2008-08-26       Impact factor: 8.317

Review 7.  A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies.

Authors:  George J DeMarco; Elizabeth A Nunamaker
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

Review 8.  Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.

Authors:  Brad Bolon; Marina Stolina; Caroline King; Scot Middleton; Jill Gasser; Debra Zack; Ulrich Feige
Journal:  J Biomed Biotechnol       Date:  2010-12-28

Review 9.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.